![Kathleen Gogas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kathleen Gogas
Keine laufenden Positionen mehr
Profil
Kathleen Gogas worked as Vice President-Preclinical Development at Symic Bio, Inc. before obtaining a doctorate degree from Albany Medical College.
Ehemalige bekannte Positionen von Kathleen Gogas
Unternehmen | Position | Ende |
---|---|---|
Symic Bio, Inc.
![]() Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kathleen Gogas
Albany Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Symic Bio, Inc.
![]() Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Health Technology |